Table 4 Summary of divided groups by Aß*56 level.

From: Longitudinal profiling of oligomeric Aβ in human nasal discharge reflecting cognitive decline in probable Alzheimer’s disease

Group

Low (Aß*56 level < 2.65)

High (Aß*56 level ≥ 2.65)

Age

76.82 ± 4.88

74.45 ± 5.77

Sex

M

F

M

F

4

7

3

8

Aß*56 level

2.01 ± 0.48

3.58 ± 0.58

Test year

1st year

2nd year

3rd year

1st year

2nd year

3rd year

MMSE

21.09 ± 3.34

21.82 ± 3.19

21.55 ± 2.97

18.82 ± 3.21

18.45 ± 4.36

17.45 ± 4.98

GDS

3.27 ± 0.45

3.36 ± 0.48

3.18 ± 0.39

3.55 ± 0.66

3.55 ± 0.66

3.82 ± 0.72

  1. The data are represented as means ± SDs. Each group was divided to include the same number of subjects based on the Aß*56 level. Low group: Aß*56 levels below 2.65, High group: Aß*56 levels above 2.65. MMSE and GDS refer to the Mini-Mental State Examination and the Global Deterioration Scale, respectively.
Back to article page